Prognostic impact of minimal residual disease at the end of consolidation in NCI standard‐risk B‐lymphoblastic leukemia: A report from the Children's Oncology Group is a research paper published in Pediatric Blood & Cancer (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1U24‐CA1961
National Institutes of Health
Grant: 73
National Institutes of Health
Grant: U10 CA180886
National Institutes of Health
Grant: U10 CA180899
National Institutes of Health
Grant: U10 CA98413
National Institutes of Health
Grant: U10 CA98543
NCI NIH HHS
Grant: U10 CA098413
NIH HHS
Grant: 1U24-CA1961
NCI NIH HHS
Grant: U24 CA196171
NCI NIH HHS
Grant: U10 CA098543
NCI NIH HHS
Grant: U24 CA196173
Sanofi
FWCI
2.28
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals